High Fiber Or Low Fat Diet Does Not Appear to Reduce Risk of Breast Cancer Recurrence More Than '5-A-Day' Diet.
Ads by Google
Women diagnosed with breast cancer carrying the BRCA1 or BRCA2 gene mutations have similar survival and death rates as women not carrying the mutations.
A group of motorcycle "Divas" will take to the road this summer, traveling across the country promoting early detection, breast cancer awareness.
Nature's Finest Candles will join Komen for the Breast Cancer Cure in this fight by offering a SHIMMER OF HOPE.
Black women are more likely to develop breast cancer tumors.
Susan G. Komen for the Cure is part of the Partnership for Breast Cancer Awareness and Research of the Americas.
African American women tend to have breast cancer tumor types that are more aggressive and have poorer prognoses.
For women at high risk of breast cancer, use of magnetic resonance imaging (MRI) plus X-ray mammography for screening will detect more breast cancers than mammography alone.
Black women who feel they have been racially discriminated against are more likely to develop breast cancer.
Young black women are more likely than white women to develop an aggressive form of breast cancer.
National Cancer Institute canceled a five-year, $100 million study designed to test the new class of breast cancer prevention drugs known as aromatase inhibitors.
Mammograms have identified only 20% of breast cancer cases among Japanese women.
Current models for recommending breast cancer gene testing can miss women with few older female relatives.
While the majority (76 percent) of women surveyed said they know at least a fair amount about breast cancer, many remain unaware of the important recent progress made in treatment.While the majority (76 percent) of women surveyed said they know at least a fair amount about breast cancer, many remain unaware of the important recent progress made in treatment.
Epeius Biotechnologies Corporation announced the expansion of ongoing clinical trials using Rexin-G to include breast cancer and all types of sarcomas that have failed standard chemotherapy.
Phase III Ixabepilone Study Demonstrated Improvement In Patients With Advanced Metastatic Breast Cancer
Bristol-Myers Squibb reported results from a large randomized Phase III study of the investigational compound ixabepilone in patients with breast cancer whose disease had rapidly progressed through, or did not respond to, prior treatment with chemotherapies.
Results from a Phase III study that showed maintenance chemotherapy with CAELYX significantly prolonged time to progression in patients with metastatic breast cancer with infrequent and manageable clinical toxicity after first-line chemotherapy.
Results of the XCALIBr trial showed that oral Xeloda in combination with Avastin effectively delayed time to disease progression in metastatic breast cancer patients with no prior history of treatment.
The robust clinical data presented for TYKERB at ASCO further demonstrate the great potential of this drug as an essential component of treatment regimens for women with HER2-positive breast cancer.
Researchers describe a new candidate breast-cancer susceptibility gene.
Researchers have linked genetic markers on eight chromosomes in the tissue surrounding breast tumors to the grade of the cancer and the spread of the disease to the lymph nodes.
Massachusetts Mutual Life Insurance Company has kicked off an extended effort to educate women, support local breast cancer-related programs, and make substantial donations to cancer research, prevention and treatment organizations throughout the country.
Regular mammography is the most efficacious screening test for the early detection of breast cancer available to women today, but fewer women in USA receive the screening test.
Giving chemotherapy to women with operable breast cancer before they have surgery - not after - helps physicians pin down the best treatment regimen and can reduce the extent of surgery.
The Office of Research on Women's Health is broadcasting the second in a series of podcasts on breast cancer "Pinn Point on Women's Health".
American Cancer Society Study Points to Plateau in Mammography as Reason for Decline in Breast Cancer Cases.
Since 1973, conflicting reports about the long-term risk of radiation for breast cancer to the heart have been published.
On Monday, May 7, women of breast cancer screening age are invited to receive a FREE mammogram at PS 149 Sojourner Truth School.
Women with a certain hereditary deformity syndrome run a nearly twenty times higher risk of contracting breast cancer than expected.